Mouse anti Human Matrix Metalloproteinase 9 (MMP9)
X2057M
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetMMP9
Overview
- SupplierNordic-MUbio
- Product NameMouse anti Human Matrix Metalloproteinase 9 (MMP9)
- Delivery Days Customer7
- Application Supplier NoteAntibody can be used for Western blotting (1-2 microg/ml) and immunohistochemistry (1-5 microg/ml). Antibody is specific for the activated form of MMP9 only. These working concentrations are merely an indication. Optimal working concentrations should, however, be evaluated by serial dilutions by the customer.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- Applications SupplierWestern Blotting;Immunohistochemistry (paraffin)
- Category SupplierPrimary antibodies
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID4A3
- ConjugateUnconjugated
- Gene ID4318
- Target nameMMP9
- Target descriptionmatrix metallopeptidase 9
- Target synonymsCLG4B; GELB; macrophage gelatinase; MANDP2; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase); matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase); matrix metalloproteinase-9; MMP-9; type V collagenase
- HostMouse
- IsotypeIgG1
- Protein IDP14780
- Protein NameMatrix metalloproteinase-9
- Scientific DescriptionCLG4B, GELB, 92 kDa gelatinase, matrix metallopeptidase 9
- Shelf life instructionSee expiration date on vial
- SourceHybridoma produced by the fusion of splenocytes from BALB/c mice immunized with a synthetic peptide derived from the N-terminus of the human MMP9 protein and mouse myeloma Ag8563 cells. Sequence common in rabbit, dog and pig
- ReactivityHuman
- Reactivity SupplierHuman
- UNSPSC12352203
References
- 1. Wang, L. et al. (2006). Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration. J. Neurosci. 26(22);5996-6003 2. Solmiari, S.B., et al. (2006). Circulating MMP2 and MMP9 in breast cancer -- potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int. J. Cancer. 119(6);1403-1411 3. Chen, X., et al. (2005). Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells. Int. J. Cancer. 116(1);52-61